Page last updated: 2024-11-03

praziquantel and Leishmaniasis, Visceral

praziquantel has been researched along with Leishmaniasis, Visceral in 1 studies

azinox: Russian drug

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y1

Reviews

1 review available for praziquantel and Leishmaniasis, Visceral

ArticleYear
Chemotherapy of parasitic diseases. Current status and new directions.
    Chinese medical journal, 1996, Volume: 109, Issue:8

    Topics: Amphotericin B; Antimalarials; Antiprotozoal Agents; Artemisinins; Humans; Leishmaniasis, Visceral;

1996